Regenstrief Research Scientist Malaz Boustani, M.D., MPH, described the use of machine learning-powered passive digital markers to detect at an earlier stage people in the U.S. healthcare system at risk for Alzheimer’s disease and related dementias. Between 50 and 80 percent of dementia cases go unnoticed.
-
Research
- Experts
In The News
View AllNew York Times features Dr. Malaz Boustani
Malaz Boustani, M.D., PhD, was featured by The New York...
Influence
View AllScreening for intimate partner violence and caregiver abuse of older or vulnerable adults: US preventive services task force recommendation statement
Published in JAMA. Here is a link to the article....
- Opportunities
Featured Fellowship
View all- About
Regenstrief is dedicated to pioneering transformative solutions for a healthier world.
- The Latest
- Experts
February 22, 2023
Dr. Boustani in Clinical Research News

"*" indicates required fields